The bronchodilator effect of NAB 365.
1. Dose response relationships for salbutamol and a new bronchodilator drug NAB 365 have been obtained in patients with reversible airways obstruction. These show that the latter is about one hundred times more potent than the former. 2. NAB 365 has a very long half-life. The implications of this are discussed.
D000328:Adult; D000402:Airway Obstruction / Q000188:drug therapy / Q000503:physiopathology; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy; D001993:Bronchodilator Agents; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D013997:Time Factors
D001993:Bronchodilator Agents; D004983:Ethanolamines; D000420:Albuterol